507 related articles for article (PubMed ID: 28384479)
1. Mutant Huntingtin Disrupts the Nuclear Pore Complex.
Grima JC; Daigle JG; Arbez N; Cunningham KC; Zhang K; Ochaba J; Geater C; Morozko E; Stocksdale J; Glatzer JC; Pham JT; Ahmed I; Peng Q; Wadhwa H; Pletnikova O; Troncoso JC; Duan W; Snyder SH; Ranum LPW; Thompson LM; Lloyd TE; Ross CA; Rothstein JD
Neuron; 2017 Apr; 94(1):93-107.e6. PubMed ID: 28384479
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
Elife; 2021 Apr; 10():. PubMed ID: 33871358
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
Cho IK; Yang B; Forest C; Qian L; Chan AWS
PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
[TBL] [Abstract][Full Text] [Related]
4. Channel nuclear pore complex subunits are required for transposon silencing in
Munafò M; Lawless VR; Passera A; MacMillan S; Bornelöv S; Haussmann IU; Soller M; Hannon GJ; Czech B
Elife; 2021 Apr; 10():. PubMed ID: 33856346
[TBL] [Abstract][Full Text] [Related]
5. The FG-repeat asymmetry of the nuclear pore complex is dispensable for bulk nucleocytoplasmic transport in vivo.
Zeitler B; Weis K
J Cell Biol; 2004 Nov; 167(4):583-90. PubMed ID: 15557115
[TBL] [Abstract][Full Text] [Related]
6. Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease.
Caron NS; Banos R; Yanick C; Aly AE; Byrne LM; Smith ED; Xie Y; Smith SEP; Potluri N; Findlay Black H; Casal L; Ko S; Cheung D; Kim H; Seong IS; Wild EJ; Song JJ; Hayden MR; Southwell AL
J Neurosci; 2021 Jan; 41(4):780-796. PubMed ID: 33310753
[TBL] [Abstract][Full Text] [Related]
7. Nuclear pore complex composition: a new regulator of tissue-specific and developmental functions.
Raices M; D'Angelo MA
Nat Rev Mol Cell Biol; 2012 Nov; 13(11):687-99. PubMed ID: 23090414
[TBL] [Abstract][Full Text] [Related]
8. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.
Chou CC; Zhang Y; Umoh ME; Vaughan SW; Lorenzini I; Liu F; Sayegh M; Donlin-Asp PG; Chen YH; Duong DM; Seyfried NT; Powers MA; Kukar T; Hales CM; Gearing M; Cairns NJ; Boylan KB; Dickson DW; Rademakers R; Zhang YJ; Petrucelli L; Sattler R; Zarnescu DC; Glass JD; Rossoll W
Nat Neurosci; 2018 Feb; 21(2):228-239. PubMed ID: 29311743
[TBL] [Abstract][Full Text] [Related]
9. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport.
Freibaum BD; Lu Y; Lopez-Gonzalez R; Kim NC; Almeida S; Lee KH; Badders N; Valentine M; Miller BL; Wong PC; Petrucelli L; Kim HJ; Gao FB; Taylor JP
Nature; 2015 Sep; 525(7567):129-33. PubMed ID: 26308899
[TBL] [Abstract][Full Text] [Related]
10. Biomechanics of the transport barrier in the nuclear pore complex.
Stanley GJ; Fassati A; Hoogenboom BW
Semin Cell Dev Biol; 2017 Aug; 68():42-51. PubMed ID: 28506890
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of nucleocytoplasmic transport through the nuclear pore complex.
Tetenbaum-Novatt J; Rout MP
Cold Spring Harb Symp Quant Biol; 2010; 75():567-84. PubMed ID: 21447814
[TBL] [Abstract][Full Text] [Related]
12. Mutant huntingtin expression in microglia is neither required nor sufficient to cause the Huntington's disease-like phenotype in BACHD mice.
Petkau TL; Hill A; Connolly C; Lu G; Wagner P; Kosior N; Blanco J; Leavitt BR
Hum Mol Genet; 2019 May; 28(10):1661-1670. PubMed ID: 30624705
[TBL] [Abstract][Full Text] [Related]
13. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.
Zhang K; Donnelly CJ; Haeusler AR; Grima JC; Machamer JB; Steinwald P; Daley EL; Miller SJ; Cunningham KM; Vidensky S; Gupta S; Thomas MA; Hong I; Chiu SL; Huganir RL; Ostrow LW; Matunis MJ; Wang J; Sattler R; Lloyd TE; Rothstein JD
Nature; 2015 Sep; 525(7567):56-61. PubMed ID: 26308891
[TBL] [Abstract][Full Text] [Related]
14. Huntingtin-mediated axonal transport requires arginine methylation by PRMT6.
Migazzi A; Scaramuzzino C; Anderson EN; Tripathy D; Hernández IH; Grant RA; Roccuzzo M; Tosatto L; Virlogeux A; Zuccato C; Caricasole A; Ratovitski T; Ross CA; Pandey UB; Lucas JJ; Saudou F; Pennuto M; Basso M
Cell Rep; 2021 Apr; 35(2):108980. PubMed ID: 33852844
[TBL] [Abstract][Full Text] [Related]
15. Mislocalization of Nucleocytoplasmic Transport Proteins in Human Huntington's Disease PSC-Derived Striatal Neurons.
Lange J; Wood-Kaczmar A; Ali A; Farag S; Ghosh R; Parker J; Casey C; Uno Y; Kunugi A; Ferretti P; Andre R; Tabrizi SJ
Front Cell Neurosci; 2021; 15():742763. PubMed ID: 34658796
[TBL] [Abstract][Full Text] [Related]
16. mHTT Seeding Activity: A Marker of Disease Progression and Neurotoxicity in Models of Huntington's Disease.
Ast A; Buntru A; Schindler F; Hasenkopf R; Schulz A; Brusendorf L; Klockmeier K; Grelle G; McMahon B; Niederlechner H; Jansen I; Diez L; Edel J; Boeddrich A; Franklin SA; Baldo B; Schnoegl S; Kunz S; Purfürst B; Gaertner A; Kampinga HH; Morton AJ; Petersén Å; Kirstein J; Bates GP; Wanker EE
Mol Cell; 2018 Sep; 71(5):675-688.e6. PubMed ID: 30193095
[TBL] [Abstract][Full Text] [Related]
17. Uninterrupted CAG repeat drives striatum-selective transcriptionopathy and nuclear pathogenesis in human Huntingtin BAC mice.
Gu X; Richman J; Langfelder P; Wang N; Zhang S; Bañez-Coronel M; Wang HB; Yang L; Ramanathan L; Deng L; Park CS; Choi CR; Cantle JP; Gao F; Gray M; Coppola G; Bates GP; Ranum LPW; Horvath S; Colwell CS; Yang XW
Neuron; 2022 Apr; 110(7):1173-1192.e7. PubMed ID: 35114102
[TBL] [Abstract][Full Text] [Related]
18. Fifty years of nuclear pores and nucleocytoplasmic transport studies: multiple tools revealing complex rules.
Floch AG; Palancade B; Doye V
Methods Cell Biol; 2014; 122():1-40. PubMed ID: 24857723
[TBL] [Abstract][Full Text] [Related]
19. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.
Lu B; Palacino J
FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320
[TBL] [Abstract][Full Text] [Related]
20. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
